Clinical Trial Update: The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients

View source ↗

Summary

This completed clinical trial evaluates whether memory B cell marker CD27 and Howell-Jolly bodies detection have value in critically ill patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Tanta University | Conditions: Sepsis | Status: COMPLETED